853755-36-9

Upstream product

• 853755-35-8 4-[3-(3-Carboxy-propylcarbamoyl)-benzoylamino]-butyric acid 
• 99-63-8 benzene-1,3-dicarbonyl dichloride 

Downstream Products

• 1206631-00-6 C₅₆H₆₈N₆O₁₂S₂ 
• 853755-42-7 C₆₆H₉₄N₈O₁₄S₂Si₂ 
• 853755-40-5 (R)-2-[(Biphenyl-4-sulfonyl)-isopropoxy-amino]-4-{4-[3-(3-{(R)-3-[(biphenyl-4-sulfonyl)-isopropoxy-amino]-3-carboxy-propylcarbamoyl}-propylcarbamoyl)-benzoylamino]-butyrylamino}-butyric acid 
• 853755-38-1 2-[(biphenyl-4-sulfonyl)-isopropoxy-amino]-4-{4-[3-(3-{3-[(biphenyl-4-sulfonyl)-isopropoxy-amino]-3-tert-butoxycarbonyl-propylcarbamoyl}-propylcarbamoyl)-benzoylamino]-butyrylamino}-butyric acid tert-butyl ester 

Relevant academic research and scientific papers

A new development of matrix metalloproteinase inhibitors: Twin hydroxamic acids as potent inhibitors of MMPs

Starting from the observation that the CbzNH(CH2)2 side chain of the potent MMP-2/MMP-14 inhibitor, benzyl-(3R)-4-(hydroxyamino)-3- [isopropoxy(1,1′-biphenyl-4yl-sulfonyl)amino]-4-oxobutylcarbamate, (R)-1 lies in a hydrophobic region